These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 18936967
1. Caveolin-1 immuno-expression in human gastric cancer: histopathogenetic hypotheses. Barresi V, Giuffre' G, Vitarelli E, Todaro P, Tuccari G. Virchows Arch; 2008 Dec; 453(6):571-8. PubMed ID: 18936967 [Abstract] [Full Text] [Related]
2. Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer. Hur H, Kim YB, Ham IH, Lee D. J Surg Oncol; 2015 Nov; 112(6):585-91. PubMed ID: 26381042 [Abstract] [Full Text] [Related]
3. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Wang YY, Ye ZY, Zhao ZS, Tao HQ, Chu YQ. Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999 [Abstract] [Full Text] [Related]
4. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression. Choi MG, Noh JH, An JY, Hong SK, Park SB, Baik YH, Kim KM, Sohn TS, Kim S. J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447 [Abstract] [Full Text] [Related]
5. Overexpression of YAP1 is correlated with progression, metastasis and poor prognosis in patients with gastric carcinoma. Hu X, Xin Y, Xiao Y, Zhao J. Pathol Oncol Res; 2014 Oct; 20(4):805-11. PubMed ID: 24643316 [Abstract] [Full Text] [Related]
6. Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma. Ueyama H, Yao T, Nakashima Y, Hirakawa K, Oshiro Y, Hirahashi M, Iwashita A, Watanabe S. Am J Surg Pathol; 2010 May; 34(5):609-19. PubMed ID: 20410811 [Abstract] [Full Text] [Related]
11. CEACAM5 has different expression patterns in gastric non-neoplastic and neoplastic lesions and cytoplasmic staining is a marker for evaluation of tumor progression in gastric adenocarcinoma. Liu JN, Wang HB, Zhou CC, Hu SY. Pathol Res Pract; 2014 Oct; 210(10):686-93. PubMed ID: 25042385 [Abstract] [Full Text] [Related]
12. Downregulated SASH1 expression indicates poor clinical prognosis in gastric cancer. Zhou N, Liu C, Wang X, Mao Q, Jin Q, Li P. Hum Pathol; 2018 Apr; 74():83-91. PubMed ID: 29320755 [Abstract] [Full Text] [Related]
13. Gastric adenocarcinoma of the fundic gland (chief cell predominant type) with brownish pigmentation. Imagawa A, Sano N. Gastrointest Endosc; 2018 May; 87(5):1358-1359. PubMed ID: 29102736 [No Abstract] [Full Text] [Related]
14. [Expression and significance of erythropoietin in human gastric carcinoma on tissue microarry]. Jiang C, Yu JX, Chen H, Wei HJ, Ma HY, Ji P. Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):559-60. PubMed ID: 17134552 [No Abstract] [Full Text] [Related]
16. [Expression of polo like kinase1 and Ki-67 in gastric carcinoma]. Lan B, Liu BY, Chen XH, Qu Y, Zhang XQ, Cai Q, Zhu ZG. Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):801-2. PubMed ID: 16545190 [No Abstract] [Full Text] [Related]
17. [Clinicopathologic and immunohistochemical study on early gastric signet-ring cell carcinoma]. Xiong ZF, Xiao H, Tan YS. Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):442-6. PubMed ID: 21055171 [Abstract] [Full Text] [Related]
19. High SLC17A9 expression correlates with poor survival in gastric carcinoma. Li J, Su T, Yang L, Deng L, Zhang C, He Y. Future Oncol; 2019 Dec; 15(36):4155-4166. PubMed ID: 31799885 [Abstract] [Full Text] [Related]
20. The pathobiological behaviors and prognosis associated with Japanese gastric adenocarcinomas of pure WHO histological subtypes. Zheng HC, Zheng YS, Xia P, Xu XY, Xing YN, Takahashi H, Guan YF, Takano Y. Histol Histopathol; 2010 Apr; 25(4):445-52. PubMed ID: 20183797 [Abstract] [Full Text] [Related] Page: [Next] [New Search]